# Enterococcus faecalis: Characteristics, Infections, Resistance and Lab Identification

Enterococcus faecalis is a Gram-positive, facultatively anaerobic coccus that normally colonizes the gastrointestinal tract of humans and animals and can cause opportunistic infections when it reaches sterile sites. Facultatively anaerobic means the organism can grow both with and without oxygen. It is a leading cause of hospital-acquired urinary tract infections, bacteremia, and endocarditis, and its capacity to acquire and spread antibiotic resistance genes makes it a major public health concern [1].

The organism was reclassified from the genus Streptococcus in 1984, and it remains one of the most clinically important enterococcal species. Along with Enterococcus faecium, it accounts for the vast majority of clinical enterococcal isolates. Laboratory identification requires attention to species-level differences, because resistance patterns and virulence profiles differ between E. faecalis and E. faecium. This article covers the key characteristics, virulence mechanisms, clinical infections, resistance profiles, and laboratory identification of E. faecalis.

## What Is Enterococcus faecalis?

Enterococcus faecalis is a member of the genus Enterococcus, which currently contains more than 50 species. The genus belongs to the family Enterococcaceae. E. faecalis is a commensal organism of the human and animal gut, meaning it normally lives in the host without causing disease. It is also an opportunistic pathogen that can survive harsh environments, including high salt concentrations, extreme pH, and the presence of bile salts.

### Taxonomy and classification

The genus Enterococcus was separated from the genus Streptococcus in 1984 based on DNA hybridization and phylogenetic studies. Enterococci were previously classified as group D streptococci. The two most clinically significant species are E. faecalis and E. faecium. E. faecalis is the more common of the two in many clinical settings, although E. faecium has been increasing in relative frequency in some hospitals [2].

### Key characteristics

| Feature | Enterococcus faecalis |
|--|--|
| Gram stain | Gram-positive cocci in pairs and short chains |
| Oxygen requirement | Facultative anaerobe |
| Hemolysis | Usually non-hemolytic (gamma), occasionally alpha or beta |
| Bile esculin | Positive |
| PYR test | Positive |
| Growth in 6.5% NaCl | Positive |
| Motility | Non-motile (most strains) |
| Habitat | Gastrointestinal tract of humans and animals |
| Clinical significance | Opportunistic pathogen, MDR nosocomial infections |

### Species distribution

E. faecalis is the most frequently isolated enterococcal species in many clinical settings. In a study of 106 urinary isolates from dogs and cats with recurrent urinary tract infections, E. faecalis accounted for 64.2% of isolates, while E. faecium accounted for 35.8% [3]. Similar predominance has been reported in bovine mastitis, where E. faecalis represented 93% of enterococcal isolates from milk samples [4].

The species distribution can shift with host age and environment. In breeding hens, a significant age-related shift from E. faecalis in early production stages to E. faecium in adult hens has been observed [5]. This highlights the importance of species-level identification rather than assuming all enterococci behave the same.

## Gram Stain and Microscopic Appearance

<!-- art-pending: scripts/editorial-illustration/specs/enterococcus-faecalis-enterococcus-faecalis.json -->

The enterococcus faecalis [gram stain](/knowledge/diagnostics/microbiology/gram-stain-morphology-identification) is a fundamental [laboratory observation](/knowledge/diagnostics/molecular/laboratory-observation). E. faecalis appears as [Gram-positive cocci](/knowledge/diagnostics/microbiology/gram-stain-descriptive-terminology), typically arranged in pairs (diplococci) or short chains. Individual cocci are spherical to ovoid and approximately 0.5 to 1.0 micrometers in diameter.

Several practical points matter when reading the Gram stain:

- **Pairs and chains**: The arrangement in pairs and short chains can resemble Streptococcus pneumoniae or viridans group streptococci. This is a common source of confusion in the clinical laboratory.
- **Gram variability**: Older cultures or cultures exposed to antibiotics can stain Gram-variable or even Gram-negative. This can lead to misidentification if the smear is taken from an aged agar plate.
- **No spores**: E. faecalis does not form spores. The absence of spores and the presence of pairs and chains help separate it from Bacillus species.
- **No capsule**: Unlike S. pneumoniae, E. faecalis does not have a prominent polysaccharide capsule visible by routine staining.

The Gram stain alone cannot differentiate E. faecalis from E. faecium. Both species look identical microscopically. Species-level identification requires biochemical testing, MALDI-TOF mass spectrometry, or molecular methods.

## Virulence Factors and Pathogenesis

E. faecalis carries a broad arsenal of virulence factors that allow it to adhere to host tissues, form biofilms, evade the immune system, and damage host cells. The presence and expression of these factors vary among strains and correlate with clinical outcomes.

### Adhesins

Adhesins are surface proteins that allow bacteria to attach to host extracellular matrix proteins. The most important adhesins in E. faecalis are Ace (collagen-binding protein) and EfaA (endocarditis- and biofilm-associated antigen).

- The ace gene was detected in 98.1% of E. faecalis isolates from bovine mastitis in Poland [6].
- The efaA gene was the most frequently detected virulence gene in multiple studies, with prevalence of 99.1% in duck isolates [7], 95.2% in clinical isolates from Iran [8], and 77.5% in clinical isolates from Jordan [9].

### Biofilm formation

Biofilm formation is a key virulence mechanism that allows E. faecalis to persist on medical devices, heart valves, and root canals. A biofilm is a structured community of bacterial cells attached to a surface and embedded in a self-produced extracellular matrix. Biofilms protect bacteria from antibiotics and host immune defenses.

- The esp gene encodes an enterococcal surface protein involved in biofilm formation and immune evasion. It was detected in 69% of clinical isolates in one study [8] and 50.6% in another [9].
- In a study from Baghdad, the esp gene was confirmed as the gene responsible for biofilm formation, and its expression was measured by real-time PCR [10].
- Biofilm production is common: 92.8% of clinical isolates were biofilm producers in one study [8], and 93.3% in another [9].
- Among E. faecalis isolates in Iran, 64% were strong biofilm formers, while E. faecium isolates were mostly moderate producers [11].

The fsr quorum sensing system regulates biofilm formation and virulence [gene expression](/blog/guides/gene-expression). Quorum sensing is a cell-to-cell communication mechanism that allows bacteria to coordinate gene expression based on population density. The fsr system controls the expression of gelatinase (gelE) and serine protease (sprE), both of which contribute to tissue damage and biofilm maturation [12]. The fsr system is considered a potential therapeutic target, and compounds that inhibit it can reduce virulence factor production [12].

### Toxins and enzymes

- **Cytolysin (cylA)**: A toxin that lyses red blood cells and immune cells. It is associated with hemolytic strains and increased virulence. The cylA gene was detected in 30% of isolates in Jordan [9] and 25% in Kenya [13].
- **Gelatinase (gelE)**: An enzyme that degrades collagen and other host proteins. The gelE gene was present in 86.5% of bovine mastitis isolates [6] and 69.7% of clinical isolates from Jordan [9].
- **Aggregation substance (asa1)**: A surface protein that promotes bacterial aggregation and conjugation, facilitating the transfer of resistance plasmids. The asa1 gene was detected in 80.6% of E. faecalis isolates from Vietnam [14] and 77.5% from Jordan [9].

### Virulence gene burden

E. faecalis consistently carries a higher virulence gene burden than E. faecium. In a study of urinary isolates from dogs and cats, E. faecalis was more likely to carry ace, gelE, asa1, cylA, fsr, and esp, and showed a higher overall virulence profile [3]. In bovine mastitis isolates, E. faecalis carried more virulence genes than E. faecium, including efaAfs (100%), ace (98.1%), gelE (86.5%), asa1 (63.5%), esp (57.7%), and cylA (17.3%) [6].

In clinical isolates from Vietnam, 64.3% of E. faecalis strains carried both asa1 and gelE genes, primarily in pus and urine samples, and these genes were notably common in MDR E. faecalis strains [14].

## Clinical Infections

E. faecalis causes a wide range of infections in humans and animals. It is an opportunistic pathogen, meaning it typically causes disease when the host is immunocompromised, when the normal microbiota is disrupted by antibiotics, or when it gains access to sterile sites through medical devices or tissue damage.

### Urinary tract infections

E. faecalis is a common cause of urinary tract infections (UTIs), particularly in patients with urinary catheters, structural abnormalities, or recurrent infections. In a study from Kenya, E. faecalis was associated with community-acquired urinary tract infections, while E. faecium was associated with hospital-acquired skin and soft tissue infections [13].

In companion animals, enterococci are increasingly recognized as opportunistic uropathogens associated with [recurrent UTIs](/knowledge/veterinary-medicine/urology-nephrology/urinary-tract-infection-in-dogs-diagnostic-rules-and-antibiotic-stewardship). A study of 106 monomicrobial urinary isolates from dogs and cats found that E. faecalis was more frequently isolated from cats than dogs (77.8% vs 54.1%) [3].

### Bacteremia and bloodstream infections

E. faecalis is a leading cause of enterococcal bacteremia, which is the presence of bacteria in the bloodstream. Bacteremia is particularly common in hospitalized patients. A genomic study of bloodstream infections in a Chinese hospital found that E. faecalis infections originated from more diverse sources than E. faecium infections, with a higher proportion of E. faecium deriving from intra-abdominal infections [2].

### Endocarditis

Enterococci are a classic cause of infective endocarditis, an infection of the heart valves. E. faecalis can cause endocarditis on native, prosthetic, and device-associated valves. The ability to form biofilms on cardiac tissue and medical devices is central to its pathogenesis [15]. Treatment of enterococcal endocarditis is challenging and typically requires prolonged combination antibiotic therapy.

### Wound and soft tissue infections

Enterococci can cause wound infections, particularly in surgical sites and diabetic ulcers. In the Kenyan study, all E. faecium isolates were obtained from hospital-acquired skin and soft tissue infections, while E. faecalis was more common in community-acquired UTIs [13].

### Oral and endodontic infections

E. faecalis is one of the most important pathogens in endodontic infections and a major cause of root canal treatment failure. It can survive in the nutrient-depleted environment of the root canal, resist intracanal medicaments, and form biofilms on dentin [16].

In a study of root filled teeth with periradicular lesions in Thailand, E. faecalis was detected in 33.3% of samples by culture and 88.9% by real-time PCR, highlighting the value of molecular methods for detection. Hemolytic strains were found in 36.4% of subjects [17].

The organism's persistence in root canals is linked to its ability to invade dentinal tubules and survive as a biofilm. Irrigation solutions such as MTAD (a mixture of doxycycline, citric acid, and a detergent) have been shown to inhibit the expression of some E. faecalis virulence factors, including efa, esp, gel, and fsr [18].

### Veterinary infections

E. faecalis is an important pathogen in [veterinary medicine](/blog/careers/veterinary-medicine-careers-from-clinical-practice-to-public-health):

- **Bovine mastitis**: E. faecalis is among the most frequently isolated environmental bacteria causing mastitis in dairy cows. In a South African study, E. faecalis represented 93% of enterococcal isolates from milk samples of cows with subclinical mastitis [4]. In Polish herds, enterococci were isolated from cases of bovine mastitis, with E. faecalis carrying more virulence genes than E. faecium [6].
- **Poultry**: E. faecalis is a commensal of poultry but also an opportunistic pathogen. A study of ducks at slaughterhouses recovered 227 E. faecalis isolates (67.8%) from cecum, cloaca, skin, and rinsed water [7]. In breeding hens, E. faecalis predominated in early production stages [5].
- **Companion animals**: E. faecalis is an opportunistic uropathogen in dogs and cats with recurrent UTIs [3].

## Antimicrobial Resistance

Antimicrobial resistance in E. faecalis is a major clinical challenge. The species has both intrinsic resistance, which is naturally present in all strains, and acquired resistance, which is gained through mutation or [horizontal gene transfer](/blog/guides/horizontal-gene-transfer).

### Intrinsic resistance

E. faecalis is intrinsically resistant to:

- Cephalosporins
- Clindamycin
- Low levels of aminoglycosides
- Trimethoprim-sulfamethoxazole (in vivo, despite apparent in vitro susceptibility)

This intrinsic resistance means that many common empiric antibiotic regimens are ineffective against enterococci.

### Acquired resistance

E. faecalis can acquire resistance to virtually all clinically useful antibiotics, including ampicillin, vancomycin, linezolid, and high levels of aminoglycosides.

#### Multidrug resistance

Multidrug resistance (MDR), defined as resistance to three or more antibiotic classes, is common in E. faecalis:

- 96% of 155 clinical E. faecalis isolates from Saudi Arabia were MDR [1].
- 90.3% of E. faecalis isolates from ducks at slaughterhouses were MDR [7].
- 27.8% of clinical Enterococcus isolates from Vietnam were MDR [14].

#### Vancomycin resistance and VRE

Vancomycin-resistant enterococci (VRE) are a major public health threat. Vancomycin is a glycopeptide antibiotic that is often used as a last-resort treatment for resistant Gram-positive infections.

The most common mechanism of vancomycin resistance in E. faecalis is the vanA gene cluster, which confers high-level resistance to both vancomycin and teicoplanin. The vanB gene confers variable resistance to vancomycin but susceptibility to teicoplanin.

- In a study from Iran, 70% of enterococcal isolates were VRE and carried the vanA gene. All E. faecium isolates were 100% resistant to vancomycin, ciprofloxacin, and levofloxacin [11].
- In a study from Iran, vancomycin resistance was detected in 15 of 42 E. faecalis isolates (35.7%) with MICs of 32 micrograms/mL or higher [8].
- In bovine mastitis isolates from South Africa, 17.2% of E. faecalis isolates from milk samples exhibited vancomycin resistance [4].
- In clinical isolates from Vietnam, vancomycin resistance was 11.1% [14].
- In a Thai hospital, the VRE detection rate was 14.5%, with 97.1% E. faecium and 2.9% E. faecalis [19].

The vanA gene is the most frequently detected vancomycin resistance determinant. In a study of E. faecalis isolates from ducks, vanA was detected in 0.4% of isolates, while vanC was more common (19.8%) [7]. In clinical isolates from Iran, vanA was detected in 19% of E. faecalis isolates [8].

#### High-level aminoglycoside resistance

High-level aminoglycoside resistance (HLGR) is clinically important because it abolishes the synergistic bactericidal effect of combining an aminoglycoside with a cell wall-active agent such as ampicillin or vancomycin. Synergy means the combined effect of two drugs is greater than the sum of their individual effects.

- In a study from Iran, all 42 E. faecalis isolates were high-level gentamicin resistant (MICs of 500 micrograms/mL or higher) [8].
- In clinical isolates from Vietnam, high-level gentamicin resistance was 34.7% [14].
- The aac(6')-Ie-aph(2")-Ia gene, which encodes a bifunctional enzyme that inactivates both gentamicin and other aminoglycosides, was detected in 100% of E. faecalis isolates in one study [8] and 75.8% of duck isolates [7].

#### Resistance to other antibiotics

Resistance rates vary widely by geographic region and sample source:

- **Erythromycin**: 82.1% in dog and cat urinary isolates [3], 78.6% in Jordan [9], 50.8% in Vietnam [14], 72.2% in ducks [7].
- **Ampicillin**: 98.9% in Jordan [9], 30.6% in Vietnam [14], 36.1% in ducks. Low resistance was observed against ampicillin in Saudi Arabia [1].
- **Tetracycline**: 95.6% in ducks [7], 83.1% in Jordan [9], 28.5% in Vietnam [14].
- **Linezolid**: 75.8% in ducks [7], but low resistance in clinical isolates [1]. Linezolid is generally considered a reliable treatment option for VRE infections in humans.
- **Rifampicin**: 78.3% in dog and cat urinary isolates [3], 68.5% in Jordan [9].

### Resistance genes

Common resistance genes in E. faecalis include:

- **ermB**: Macrolide resistance, detected in 90.3% of duck isolates [7] and 78.6% of clinical isolates [8].
- **tetM**: Tetracycline resistance, detected in 84.6% of duck isolates [7] and 94.3% of tetracycline-resistant bovine mastitis isolates [6].
- **optrA**: Oxazolidinone resistance, detected in 90.7% of duck isolates [7].
- **aph(3')-III**: Aminoglycoside resistance, detected in 86.8% of duck isolates [7].
- **blaZ**: Beta-lactamase, detected in 76.7% of duck isolates [7].
- **aac(6')-Ie-aph(2")-Ia**: High-level aminoglycoside resistance, detected in 75.8% of duck isolates [7] and 100% of clinical isolates [8].

### CRISPR-Cas systems and resistance

CRISPR-Cas systems are bacterial adaptive immune systems that can limit the acquisition of foreign DNA, including antibiotic resistance plasmids. In a study from Iran, 86.6% of enterococcal isolates harbored CRISPR-Cas repeat-spacer arrays, with a significantly higher prevalence in E. faecalis than in E. faecium [20]. The presence of CRISPR-Cas systems may influence the acquisition and spread of resistance genes.

### Biofilm-associated resistance

Biofilm formation significantly increases the effective resistance of E. faecalis to antibiotics. In a rat foreign body osteomyelitis model, no differences were observed among wild-type and mutant strains in planktonic and biofilm antimicrobial susceptibilities to ampicillin, vancomycin, daptomycin, linezolid, and tetracycline, yet [biofilm infections](/knowledge/diagnostics/microbiology/biofilm-tolerance-vs-resistance) remain difficult to eradicate [15]. Standard antimicrobial susceptibility testing measures planktonic (free-floating) bacteria and does not capture the reduced susceptibility of biofilm-associated cells.

## Laboratory Identification

Accurate laboratory identification of E. faecalis requires a combination of phenotypic, biochemical, and molecular methods.

### Culture and isolation

E. faecalis grows on standard laboratory media, including blood agar and chocolate agar. It is a facultative anaerobe and grows well in ambient air with 5% CO2.

Selective and differential media are useful for isolating enterococci from mixed cultures:

- **Bile esculin agar**: Enterococci hydrolyze esculin in the presence of bile, producing a black precipitate. This is the basis of the bile esculin test.
- **Enterococcosel agar**: A selective medium containing bile, esculin, and sodium azide. Enterococci produce black colonies.
- **6.5% NaCl broth**: Enterococci tolerate high salt concentrations, which helps differentiate them from most streptococci.

### Biochemical tests

Key biochemical tests for enterococcal identification:

- **PYR test**: E. faecalis hydrolyzes L-pyrrolidonyl-beta-naphthylamide (PYR), producing a red color after addition of cinnamaldehyde reagent. Group A streptococci are also PYR positive, so this test alone is not sufficient.
- **Bile esculin test**: Positive for all enterococci.
- **Growth in 6.5% NaCl**: Positive for enterococci.
- **LAP test**: Leucine aminopeptidase positive, which helps differentiate enterococci from some other Gram-positive cocci.

### Species-level differentiation

![Decision path from a Gram-positive coccus in pairs or chains through basic tests to MALDI-TOF or ddl PCR for species-level identification.](/article-images/illustrations/enterococcus-faecalis-species-triage.webp)

Differentiating E. faecalis from E. faecium is essential because of differences in resistance patterns and clinical significance.

- **Mannitol fermentation**: E. faecalis ferments mannitol, while E. faecium does not (though some strains may vary).
- **Arabinose fermentation**: E. faecium ferments arabinose, while E. faecalis does not.
- **Motility**: Both E. faecalis and E. faecium are non-motile; motile species include E. gallinarum and E. casseliflavus.

### MALDI-TOF mass spectrometry

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) has become the standard method for species-level identification of enterococci in many clinical laboratories. It is rapid, accurate, and cost-effective. MALDI-TOF MS was used to identify E. faecalis and E. faecium isolates in studies from Saudi Arabia [1] and South Africa [4].

### Molecular methods

[Polymerase chain reaction](/knowledge/molecular-biology/polymerase-chain-reaction) (PCR) targeting species-specific genes provides definitive identification:

- **ddl gene**: The D-alanine-D-alanine ligase gene is species-specific. PCR targeting ddl confirmed the predominance of E. faecalis (93%) in bovine mastitis milk samples [4].
- **[Multiplex PCR](/knowledge/diagnostics/molecular/multiplex-pcr-design-optimization-and-troubleshooting) for van genes**: Multiplex PCR for vanA, vanB, vanC1, and vanC2 is used to detect vancomycin resistance determinants [3].
- **Virulence gene PCR**: PCR for virulence genes such as ace, gelE, asa1, cylA, esp, and efaA is used in epidemiological studies [3], [8], [6].

### Molecular typing

Molecular typing methods are used for epidemiological investigations:

- **Multilocus sequence typing (MLST)**: MLST characterizes isolates by sequencing housekeeping genes. Common sequence types (STs) of E. faecalis include ST16 and ST179, which belong to clonal complex 16 (CC16) [1], [2].
- **ERIC-PCR**: Enterobacterial repetitive intergenic consensus PCR is a fingerprinting method used to assess genetic diversity [8].

### Antimicrobial susceptibility testing

Antimicrobial susceptibility testing (AST) of E. faecalis should be performed on clinically significant isolates. Methods include:

- **Disk diffusion**: The Kirby-Bauer method is used for routine susceptibility testing [3], [14].
- **Broth microdilution**: This method determines the minimum inhibitory concentration (MIC) and is the reference method for vancomycin and gentamicin testing [8].
- **E-test**: A gradient diffusion method that provides MIC values [11].
- **Automated systems**: The VITEK-2 system is commonly used in clinical laboratories [1].

Key antibiotics to test include ampicillin, vancomycin, linezolid, daptomycin, tigecycline, and high-level gentamicin and streptomycin.

## Common Mistakes and Limitations

Several practical pitfalls affect the laboratory diagnosis and clinical management of E. faecalis infections.

**Confusing E. faecalis with E. faecium**. The two species look identical on Gram stain and many biochemical tests. Species-level identification is essential because E. faecium is more often resistant to ampicillin and vancomycin, and treatment choices differ. MALDI-TOF or PCR should be used when species-level identification matters clinically.

**Overinterpreting Gram stain morphology**. E. faecalis in pairs can be mistaken for Streptococcus pneumoniae, and short chains can resemble viridans group streptococci. Gram-variable staining in old cultures can lead to misidentification as Gram-negative organisms.

**Assuming all VRE are E. faecium**. While E. faecium is the more common VRE species in many hospitals, E. faecalis can also carry vanA and cause VRE infections [11], [2].

**Assuming vancomycin resistance is the only problem**. E. faecalis can be resistant to many other antibiotics, including ampicillin, linezolid, and high levels of aminoglycosides. High-level aminoglycoside resistance abolishes the synergistic killing that is critical for treating enterococcal endocarditis.

**Standard AST does not capture biofilm resistance**. Biofilm-associated E. faecalis is substantially more resistant to antibiotics than planktonic bacteria, and standard susceptibility testing does not predict the response of biofilm infections [15].

**Surveillance data may not reflect clinical isolates**. Studies of enterococci from animals, food, or environmental samples may show different resistance profiles than clinical isolates from humans. For example, linezolid resistance was 75.8% in duck isolates [7], but low in clinical isolates [1].

**Individual cases need a veterinarian or physician**. This article provides laboratory and microbiological context, but diagnosis and treatment decisions must be made by a qualified clinician.

## Quick Review

- Enterococcus faecalis is a Gram-positive, facultatively anaerobic coccus that appears in pairs and short chains on Gram stain and is PYR positive, bile esculin positive, and grows in 6.5% NaCl.
- It is a normal gut commensal and an opportunistic pathogen causing UTIs, bacteremia, endocarditis, wound infections, and endodontic infections.
- E. faecalis carries more virulence genes than E. faecium, including ace, gelE, asa1, cylA, esp, and efaA, and is a strong biofilm former.
- Antimicrobial resistance is a major problem, with MDR rates of 27.8% to 96% depending on the setting.
- Vancomycin resistance (VRE) is mediated primarily by vanA, and high-level gentamicin resistance is mediated by aac(6')-Ie-aph(2")-Ia.
- Laboratory identification requires species-level methods such as MALDI-TOF or PCR, because Gram stain and basic biochemical tests cannot reliably differentiate E. faecalis from E. faecium.
- Standard antimicrobial susceptibility testing does not predict the response of biofilm-associated infections.

## Related Guides

- [Enterococcus cecorum in Broilers: Spondylitis, Vertebral Osteomyelitis, and Control](/knowledge/bacteria/avian-bacteria/enterococcus-cecorum-broilers-spondylitis-osteomyelitis): Another enterococcal species causing spinal infections in broilers; useful poultry differential
- [How to Detect Functional Genes in Long-Read Metagenomes: A Guide to Antibiotic Resistance and Virulence Factor Annotation](/knowledge/bioinformatics/how-to-detect-functional-genes-in-long-read-metagenomes-a-guide-to-antibiotic-resistance-and-virulen): Covers detecting resistance and virulence genes in metagenomes, complementing PCR identification
- [Target Modification as a Mechanism of Antibiotic Resistance](/knowledge/bacteria/general/target-modification-as-a-mechanism-of-antibiotic-resistance-from-mutations-to-post-translational-mod): Vancomycin resistance often involves target modification; relevant to VRE mechanisms
- [Target Protection in Antibiotic Resistance](/knowledge/bacteria/general/target-protection-in-antibiotic-resistance-how-ribosomal-protection-proteins-and-qnr-proteins-confer): TetM, mentioned for tetracycline resistance, is a target protection mechanism
- [Antibiotic Resistance in Poultry: A Comprehensive Review of Bacterial Pathogens](/knowledge/bacteria/avian-bacteria/antibiotic-resistance-poultry-bacterial-pathogens): Poultry antibiotic resistance review provides broader context for E. faecalis in flocks
- [Metagenomics Antibiotic Resistance Pipeline: Step-by-Step Guide](/knowledge/diagnostics/microbiology/metagenomics-antibiotic-resistance-pipeline): Step-by-step metagenomics resistance pipeline aids detection of resistance genes
- [Pyelonephritis in Dogs: Diagnosing Kidney Infection and Antibiotic Protocol](/knowledge/veterinary-medicine/urology-nephrology/pyelonephritis-in-dogs-diagnosing-kidney-infection-and-antibiotic-protocol): Canine pyelonephritis diagnosis and treatment relevant to recurrent E. faecalis UTIs
- [How to Validate Your Gram Stain Protocol After Repeated Failures](/knowledge/diagnostics/microbiology/gram-stain-protocol-validation): Gram stain troubleshooting helps avoid misidentification of enterococci in the lab

## Frequently Asked Questions

### What does Enterococcus faecalis look like on Gram stain?

E. faecalis appears as Gram-positive cocci in pairs (diplococci) and short chains. Individual cells are spherical to ovoid and approximately 0.5 to 1.0 micrometers in diameter. Older cultures can stain Gram-variable, which can lead to misidentification.

### How is Enterococcus faecalis different from Enterococcus faecium?

E. faecalis and E. faecium are the two most clinically important enterococcal species. E. faecalis is more common in many settings and carries a higher burden of virulence genes [3], [6]. E. faecium is more frequently resistant to ampicillin and vancomycin and is the dominant VRE species in many hospitals [19]. Species-level identification requires MALDI-TOF or PCR, not just biochemical tests.

### What infections does Enterococcus faecalis cause?

E. faecalis causes urinary tract infections, bacteremia, infective endocarditis, wound and soft tissue infections, and endodontic (root canal) infections. It is also an important cause of bovine mastitis and opportunistic infections in companion animals and poultry [3], [4].

### What is VRE?

![Table comparing E. faecalis and E. faecium on mannitol and arabinose fermentation, motility, virulence genes, resistance and share of hospital VRE.](/article-images/illustrations/enterococcus-faecalis-faecalis-faecium.webp)

VRE stands for vancomycin-resistant enterococci. Vancomycin is a glycopeptide antibiotic used to treat serious Gram-positive infections. VRE are resistant to vancomycin, most commonly through the vanA gene cluster, which also confers resistance to teicoplanin. VRE infections are difficult to treat and are a major hospital-acquired concern [11], [19].

### How do laboratories identify Enterococcus faecalis?

Laboratories use a combination of culture on selective media, biochemical tests (PYR, bile esculin, 6.5% NaCl), and species-level methods such as MALDI-TOF mass spectrometry or PCR targeting the ddl gene. Antimicrobial susceptibility testing is performed by disk diffusion, broth microdilution, or automated systems [1], [4], [8].

### What antibiotics treat Enterococcus faecalis infections?

Treatment depends on the site and severity of infection and the resistance profile of the isolate. Ampicillin is a first-line agent for susceptible strains. For serious infections such as endocarditis, ampicillin or vancomycin is combined with an aminoglycoside for synergistic killing, unless the isolate has high-level aminoglycoside resistance. Linezolid, daptomycin, and tigecycline are options for resistant strains, including VRE [13], [1], [11].

<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [{
    "@type": "Question",
    "name": "What does Enterococcus faecalis look like on Gram stain?",
    "acceptedAnswer": {
      "@type": "Answer",
      "text": "E. faecalis appears as Gram-positive cocci in pairs (diplococci) and short chains. Individual cells are spherical to ovoid and approximately 0.5 to 1.0 micrometers in diameter. Older cultures can stain Gram-variable, which can lead to misidentification."
    }
  }, {
    "@type": "Question",
    "name": "How is Enterococcus faecalis different from Enterococcus faecium?",
    "acceptedAnswer": {
      "@type": "Answer",
      "text": "E. faecalis and E. faecium are the two most clinically important enterococcal species. E. faecalis is more common in many settings and carries a higher burden of virulence genes. E. faecium is more frequently resistant to ampicillin and vancomycin and is the dominant VRE species in many hospitals. Species-level identification requires MALDI-TOF or PCR, not just biochemical tests."
    }
  }, {
    "@type": "Question",
    "name": "What infections does Enterococcus faecalis cause?",
    "acceptedAnswer": {
      "@type": "Answer",
      "text": "E. faecalis causes urinary tract infections, bacteremia, infective endocarditis, wound and soft tissue infections, and endodontic (root canal) infections. It is also an important cause of bovine mastitis and opportunistic infections in companion animals and poultry."
    }
  }, {
    "@type": "Question",
    "name": "What is VRE?",
    "acceptedAnswer": {
      "@type": "Answer",
      "text": "VRE stands for vancomycin-resistant enterococci. Vancomycin is a glycopeptide antibiotic used to treat serious Gram-positive infections. VRE are resistant to vancomycin, most commonly through the vanA gene cluster, which also confers resistance to teicoplanin. VRE infections are difficult to treat and are a major hospital-acquired concern."
    }
  }, {
    "@type": "Question",
    "name": "How do laboratories identify Enterococcus faecalis?",
    "acceptedAnswer": {
      "@type": "Answer",
      "text": "Laboratories use a combination of culture on selective media, biochemical tests (PYR, bile esculin, 6.5% NaCl), and species-level methods such as MALDI-TOF mass spectrometry or PCR targeting the ddl gene. Antimicrobial susceptibility testing is performed by disk diffusion, broth microdilution, or automated systems."
    }
  }, {
    "@type": "Question",
    "name": "What antibiotics treat Enterococcus faecalis infections?",
    "acceptedAnswer": {
      "@type": "Answer",
      "text": "Treatment depends on the site and severity of infection and the resistance profile of the isolate. Ampicillin is a first-line agent for susceptible strains. For serious infections such as endocarditis, ampicillin or vancomycin is combined with an aminoglycoside for synergistic killing, unless the isolate has high-level aminoglycoside resistance. Linezolid, daptomycin, and tigecycline are options for resistant strains, including VRE."
    }
  }]
}
</script>

## Sources

1. [Genomic analysis of multidrug-resistant clinical Enterococcus faecalis isolates for antimicrobial resistance genes and virulence factors from the western region of Saudi Arabia](https://pubmed.ncbi.nlm.nih.gov/30962917/)
2. [Comparative genomic characterization and antimicrobial resistance of bacteremia-causing Enterococcus faecium and Enterococcus faecalis in a Chinese hospital.](https://pubmed.ncbi.nlm.nih.gov/42554460/)
3. [Virulence factors and antimicrobial resistance profiles of Enterococcus faecalis and Enterococcus faecium isolates from urine samples of dogs and cats](https://pubmed.ncbi.nlm.nih.gov/42551988/)
4. [Antimicrobial resistance and virulence gene profiles of Enterococcus faecalis and Enterococcus faecium isolated from subclinical bovine mastitis milk and cow dung](https://pubmed.ncbi.nlm.nih.gov/41413635/)
5. [Antimicrobial Resistance and Species Dynamics of Enterococcus faecalis and Enterococcus faecium in Breeding Hens: Phenotypic and Genotypic Characterization.](https://pubmed.ncbi.nlm.nih.gov/42655815/)
6. [Prevalence, Molecular Characterisation and Antimicrobial Resistance of Enterococcus faecalis and Enterococcus faecium Isolated from Bovine Mastitis in Poland.](https://pubmed.ncbi.nlm.nih.gov/42347225/)
7. [Molecular characterization of antimicrobial resistance and virulence factors of Enterococcus faecalis from ducks at slaughterhouses](https://pubmed.ncbi.nlm.nih.gov/35172230/)
8. [Molecular Profiling of CRISPR-Cas System, Virulence Traits, and Antimicrobial Resistance in Enterococcus faecalis Clinical Isolates.](https://pubmed.ncbi.nlm.nih.gov/42516529/)
9. [Detection of Virulence Factors and Antimicrobial Susceptibility among Clinical Strains of Enterococcus faecalis.](https://pubmed.ncbi.nlm.nih.gov/41029013/)
10. [Detection of Some Virulence Factors, Antibiotics Resistant and esp Gene Expression in Enterococcus faecalis bacteria](https://doi.org/10.30526/38.4.3756)
11. [High Prevalence of vanA-Positive Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium: Antibiotic Resistance, Biofilm Formation, and Virulence Profiles.](https://pubmed.ncbi.nlm.nih.gov/42985573/)
12. [Polidocanol inhibits Enterococcus faecalis virulence factors by targeting fsr quorum sensing system](https://pubmed.ncbi.nlm.nih.gov/39415105/)
13. [Determination of Enterococcus faecalis and Enterococcus faecium Antimicrobial Resistance and Virulence Factors and Their Association with Clinical and Demographic Factors in Kenya](https://pubmed.ncbi.nlm.nih.gov/36405031/)
14. [Antimicrobial resistance and virulence-associated genes of Enterococcus faecalis and Enterococcus faecium clinical isolates in Central Vietnam](https://doi.org/10.34071/jmp.2024.6.12)
15. [Evaluation of the Enterococcus faecalis Biofilm-Associated Virulence Factors AhrC and Eep in Rat Foreign Body Osteomyelitis and In Vitro Biofilm-Associated Antimicrobial Resistance](https://pubmed.ncbi.nlm.nih.gov/26076451/)
16. [Oral cavity infection by Enterococcus faecalis: virulence factors and pathogenesis](https://doi.org/10.1097/MRM.0000000000000168)
17. [Prevalence and virulence factors of haemolytic Enterococcus faecalis isolated from root filled teeth associated with periradicular lesions: A laboratory investigation in Thailand.](https://pubmed.ncbi.nlm.nih.gov/38483342/)
18. [Evaluation of the Effect of MTAD on Expression of Enterococcus faecalis Virulence Factors Considering the Role of Different Obturating Materials](https://pubmed.ncbi.nlm.nih.gov/30842799/)
19. [Molecular insights into antimicrobial resistance and virulence in hospital-associated of vancomycin-resistant Enterococcus faecium isolates in a tertiary hospital in Bangkok Thailand.](https://pubmed.ncbi.nlm.nih.gov/41875102/)
20. [Investigating the prevalence of CRISPR-Cas system and their association with antibiotic resistance genes and virulence factors in Enterococcus faecalis and Enterococcus faecium strains isolated from hospitalized patients.](https://pubmed.ncbi.nlm.nih.gov/40311759/)